Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
CoCo Therapeutics Ltd., which will research the role of the nuclear receptor, retinoic acid receptor (RAR), in Alzheimer’s disease, has received an undisclosed amount of seed funding from Advent Venture Partners. An Advent general partner joined CoCo’s board as chairman.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?